Corbus Pharmaceuticals Holdings Inc.
(NASDAQ:CRBP)
Company Description:
Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.
Latest News & Stories on Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Please reload